In malignancies such as hepatocellular carcinoma, colorectal cancer, and breast cancer, abnormal expression of NAT10 has been associated with tumor progression by promoting cell proliferation, migration, and invasion [16, 17]. Here, NAT10 is linked to breast carcinoma.